Campone M, Bachelot T, Treilleux I, Pistilli B, et al. A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial). Eur J Cancer 2021;158:169-180.
PMID: 34678678